34 C
Lahore

SEARL has concluded an exclusive licensing & supply agreement with Livzon Mapharm Inc

Must read

SEARL in a notice informed that it has concluded an exclusive licensing & supply agreement with Livzon Mapharm Inc for the “recombinant novel coronavirus vaccine(V-01)’ which also covers manufacturing transition of (V-01) in Pakistan.

More articles

Latest article